Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonviral ocular gene transfer.

S Kachi1, Y Oshima, N Esumi

  • 1The Department of Ophthalmology and Neuroscience, Baltimore, MD 21287-9277, USA.

Gene Therapy
|March 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

This story shall the good [surgeon] teach.

Annals of the Royal College of Surgeons of England·2026
Same author

Certification of radiation protection professionals in Australia and New Zealand.

Annals of the ICRP·2026
Same author

To be… an author.

Annals of the Royal College of Surgeons of England·2025
Same author

Knowledge and caring.

Annals of the Royal College of Surgeons of England·2025
Same author

"It's no use going back to yesterday".

Annals of the Royal College of Surgeons of England·2024
Same author

Innovation and the publishing gambit.

Annals of the Royal College of Surgeons of England·2024

Nonviral gene transfer in the eye using electroporation or lipofection shows promise for retinal gene therapy. These methods enable efficient gene delivery and promoter evaluation, with optimized techniques minimizing retinal damage.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Biotechnology

Background:

  • Nonviral gene transfer methods are being explored for ocular applications.
  • Efficient and safe gene delivery to the eye remains a challenge.

Purpose of the Study:

  • To investigate electroporation and lipofection for nonviral gene transfer in the eye.
  • To assess the efficacy and safety of these methods for delivering genetic material to retinal cells.
  • To evaluate their potential for testing tissue-specific promoters in vivo.

Main Methods:

  • Subretinal, intravitreous, and periocular injections of plasmid DNA.
  • Combination of plasmid injection with electroporation at varying voltages.
  • Plasmid DNA delivery using media promoting lipoplex formation (Lipofectamine2000, NeuroPorter).

Related Experiment Videos

  • Assessment of gene expression (LacZ staining) and retinal damage (histology, ERGs).

    • Main Results:

    • Electroporation significantly enhanced gene transfer efficiency at all injection sites.
    • Optimized electroporation (3.4 V/mm) achieved substantial transduction without photoreceptor damage.
    • Lipofection with 10% NeuroPorter enabled RPE cell transduction without adverse effects.
    • Gene expression was detectable for at least 14 days and could be reinduced.

    Conclusions:

    • Electroporation and lipofection are viable experimental tools for ocular gene transfer.
    • These methods facilitate the evaluation of tissue-specific promoters and transgene effects in the retina.
    • Optimized nonviral gene transfer holds potential for treating retinal and choroidal diseases.